News

A startup that’s helping us better understand the bugs that live in us just raised $83 million to start developing treatments for diseases like cancer

Microbiome startup uBiome, best known for its tests that sequence the bugs living in us, is expanding into drug development. Boosted by $US83 million in series C funding, the San Francisco-based startup plans to take the information it’s gathered to create therapies that act on the microbiome to treat conditions […]
A startup that’s helping us better understand the bugs that live in us just raised $83 million to start developing treatments for diseases like cancer
« Previous Page